VHCP Management III »

89bio shares owned by VHCP Management III

Quarter-by-quarter ownership of 89bio (ETNB) shares owned by VHCP Management III from 13F filings

Historical chart of VHCP Management III investment in 89bio

Tip: Access up to 7 years of quarterly data

All positions including 89bio held by VHCP Management III consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 89bio by VHCP Management III

Quarter filed Position value Share count Share price at filing
2019-12-31 $25M 959k 26.29

More positions owned by VHCP Management III

Axsome Therapeutics (AXSM)
Constellation Pharmceticls I
Milestone Pharmaceuticals (MIST)
Relmada Therapeutics (RLMD)
89bio (ETNB)
10x Genomics Inc Cl A (TXG)
Forty Seven
Intra Cellular Therapies (ITCI)
Iveric Bio
Kalvista Pharmaceuticals (KALV)
Adverum Biotechnologies
Marinus Pharmaceuticals
Mersana Therapeutics (MRSN)
Myovant Sciences
Nextcure (NXTC)

View all positions for VHCP Management III

Top funds holding 89bio

Henderson Group
RA Capital Management
Suvretta Capital Management
BlackRock
Rtw Investments
BVF
Vanguard Group
State Street Corporation
Pictet Asset Management Holding SA
Westfield Capital Management Company
Deep Track Capital
Citadel Advisors
Geode Capital Management
Redmile Group
Frazier Life Sciences Management

View all funds holding 89bio